CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President, CEO and Director bought 1,522,500 shares at $10.00 ($15,225,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,522,500 shares at $10.00 ($15,225,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 1,522,500 shares at $10.00 ($15,225,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 49,986 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Surgical Officer acquired 7,877 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 2,625 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Regulatory Officer acquired 52,519 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 11 of 12 · 235 filings